Neal D E
Urol Res. 1994;22(2):61-6. doi: 10.1007/BF00310993.
Men with symptoms of prostatism form a heterogenous group. The best treatment of proven obstruction or retention in fit men remains transurethral prostatectomy (TURP). Men presenting with symptoms of prostatism may have bladder outflow obstruction, detrusor instability or weak bladder contraction leading to low pressure/low flow voiding so it is perhaps not surprising that only 75% of men selected for TURP purely on the basis of symptoms have a good outcome. Pressure flow studies are the only precise method of diagnosing outflow obstruction. The problem of accurately diagnosing obstruction before treatment is started applies particularly to trials of new treatments such as lasers, high energy focused ultrasound and drugs. Laser treatment is producing short term results that are slightly inferior to TURP but may have less morbidity. The role of conservative treatment is important in selected men. Men who have severe intercurrent illness may be treated by means of intra-prostatic stents. In order to accurately assess a new treatment it is necessary to determine the short-term mortality, the morbidity, complication rate and outcome as well as the cost-effectiveness, long-term outcome and patient preference. These conditions have not yet been met for any of the new treatments for prostatism.
有前列腺增生症状的男性构成了一个异质性群体。对于身体状况良好的男性,经证实存在梗阻或潴留的最佳治疗方法仍是经尿道前列腺切除术(TURP)。出现前列腺增生症状的男性可能存在膀胱出口梗阻、逼尿肌不稳定或膀胱收缩无力导致低压/低流量排尿,因此,仅根据症状选择进行TURP的男性中只有75%预后良好,这或许并不奇怪。压力流研究是诊断出口梗阻的唯一精确方法。在开始治疗前准确诊断梗阻的问题尤其适用于激光、高能聚焦超声和药物等新治疗方法的试验。激光治疗产生的短期效果略逊于TURP,但发病率可能较低。保守治疗在特定男性中具有重要作用。患有严重并发疾病的男性可通过前列腺内支架进行治疗。为了准确评估一种新治疗方法,有必要确定短期死亡率、发病率、并发症发生率和治疗效果,以及成本效益、长期效果和患者偏好。目前,针对前列腺增生的任何一种新治疗方法都尚未满足这些条件。